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better understanding of the mechanisms of male-to-female human immunodeficiency virus (HIV-1) transmission could ultimately decrease the spread of HIV/AIDS. Worldwide, HIV-1 infects over 2.5 million people annually, 60% of whom are women. The precise mechanisms of HIV-1 sexual transmission remain elusive, yet the majority of all female HIV-1 infections are the result of heterosexual intercourse with an infected male partner (1) .
To establish infection in the female reproductive tract (FRT), HIV-1 in male ejaculate must overcome numerous innate and adaptive immune factors, traverse the genital epithelium, and establish infection in underlying CD4 ϩ target cells. How the virus achieves this remains poorly defined. Heterosexual transmission models suggest HIV-1 may only reach resident tissue immune cells through tears in the squamous epithelium or by transcytosis through the single layer of cells of the endocervix. However, other studies show HIV-1 infection of intact FRT tissues. By identification of nuances of the FRT that permit HIV-1 transmission, new prevention strategies can be developed.
The epithelial barriers in the FRT that HIV-1 must transverse are the simple columnar epithelium of the endocervix and upper reproductive tract (Fig. 1A) and/or the stratified squamous epithelia of the ectocervix and vagina (Fig. 1B to F) . The columnar epithelium of the endocervix and upper FRT may provide an easier route for HIV-1 to access target cells compared to squamous epithelium, since the former is composed of a single layer of cells with a thickness of 10 to 30 m, placing potential HIV-1 target cells at a closer proximity to the lumen (2) . However, a coating of mucus and cell-associated mucins protect this potentially delicate barrier. Further, the columnar epithelium of the endocervix comprises only a small portion of the total surface area exposed to virus-containing ejaculate (3) .
In contrast, the squamous epithelium of the ectocervix and vagina of the lower FRT is a thick multilayered structure that is thought to pose a significant physical barrier to small molecule ingress, such as HIV-1 ( Fig. 1C) (2) . Furthermore, the lower FRT is the primary area that comes in contact with seminal fluid containing infectious virus and comprises the majority of the total exposed surface area of the female genitalia. Moreover, various cellular proteins hold both columnar and squamous epithelial cells together. These proteins form tight junctions (TJs), desmosomes, and adherens junctions (AJs) that decrease tissue permeability, limit epithelial shearing, and block penetration of small macromolecules, including virions (4, 5) .
For infection to occur following vaginal intercourse, HIV-1 must gain access to CD4 ϩ cells, including T cells, macrophages, dendritic cells, and Langerhans cells (LCs) (2, 6) . The prevalence and distribution of these cells in humans and macaques are well described, indicating the endocervix as having the most superficial target cell populations, although devoid of LCs-a cell type found primarily within the suprabasal layers of the squamous epithelium (3, (7) (8) (9) . Notably, the ectocervix has a slightly higher density of LCs than the vagina, but in both tissues, the underlying target cells are protected by a robust squamous epithelium (3) .
Current opinions posit that intact squamous epithelia provide an impenetrable barrier against HIV-1 transmission, as epithelial cells themselves are not permissive to HIV-1 infection (3). However, LCs within the squamous suprabasal layer can become infected and also mediate transinfection by transmitting virus to other target cells deeper within the sub-basal milieu (3) . Furthermore, CD4
ϩ cells infiltrating the epithelial barrier can act as potential target cells to initiate transmission (10) .
The rhesus macaque vaginal transmission model suggests the virus interacts quickly with mucosal barriers, and cell-free virus can rapidly penetrate the female mucosa. By intravaginally applying virus, followed by an acetic acid lavage 30 min later, researchers were able to illustrate that virus can rapidly reach places where the virus is no longer sensitive to the low pH of the vaginal vault (11, 12) . Additionally, a number of studies utilizing fluorescently labeled virions and cervical explant cultures suggest that HIV-1 can penetrate intact epithelial barriers (13) (14) (15) . However, these studies were confounded by FRT tissue autofluorescence, and consequently it was difficult, if not impossible, to distinguish background fluorescence from the fluorescent signal generated by green fluorescent protein (GFP)-labeled virions.
To overcome confounding tissue autofluorescence, we developed a novel methodology that enabled unequivocal identification of individual virions within tissue sections. Using virions labeled with photoactivatable GFP-Vpr (PA-GFP) (16), we could identify virions displaying signal only after photoactivation. Here we reveal that PA-GFP HIV-1 can penetrate both the intact columnar and squamous epithelial barriers of human cervical explants and living macaques to depths where they can encounter potential target cells. The degree of virus penetration is determined by the concentration of virus, efficiency of barrier function, and the presence and integrity of cellular junctions.
MATERIALS AND METHODS
Virus generation. HIV-1-GFP-Vpr constructs (R5-HIV-1 Ba-L , R5-HIV-1 R73yu , X4-HIV-1 HXB2/Bru3 , or HIV-1 ⌬Env ) were generated as previously described (17) , with PA-GFP substituted for regular GFP (16) . Virus generation involved polyethylenimine (PEI) transfection of 293T cells in RPMI 1640 medium containing 10% heat-inactivated fetal calf serum (FCS), 100 U/ml penicillin, 100 g/ml streptomycin, and 2 mM L-glutamine. Thirty-eight to 40 h after transfection, virus was harvested, filtered (0.45-m-pore size), and stored at Ϫ80°C. Virus characterization. During sample imaging, tissue autofluorescence was defined in the fluorescein isothiocyanate (FITC) channel, and tissue samples were then photoactivated using a 413-nm light and scanned again in the FITC channel. Newly detected signals were the product of photoactivation and revealed labeled virions. PA-GFP-labeled HIV-1 was spinoculated onto a coverslip and stained with anti-p24 and anti-p17 antibodies to confirm that all PA-GFP fluorescence was associated with viral proteins. Viral p24 capsid concentration was determined by enzyme-linked immunosorbent assay (ELISA) (PerkinElmer). Criteria to ensure visualization of photoactivated virions included a minimum 2-fold increase in intensity postphotoactivation. Postphotoactivation GFP signal intensity was measured using softWoRx line profiling software. Additional criteria included a virus size of at least 2 pixels and encompassing 3 or more consecutive z-scans.
Tissue source and culture. A total of 35 cervical tissue samples were obtained from consenting donors following surgery at Northwestern Memorial Hospital. All samples were collected in accordance with institutional review board (IRB) guidelines and with ethics approval. Tissue was collected and processed within 2 h of surgery and dissected into 1-cm 3 ectocervical and endocervical nonpolarized explants. Each explant was inoculated with 500 l of unconcentrated PA-GFP-labeled R5-HIV-1 Ba-L , R5-HIV-1 R73yu , X4-HIV-1 HXB2/Bru3 , or HIV-1 ⌬EnvBru virus (ϳ100 to 1,000 ng/ml p24) in supplemented RPMI 1640 medium and cultured in a 5% CO 2 incubator at 37°C for 4 h. After virus incubation, all donor tissue was snap-frozen at Ϫ80°C, in optimal cutting temperature (OCT) compound, with the mucosal epithelium facing to the left of the cryomold. Tissue was sectioned (12 m), immunofluorescently stained for target cells, cellular components, and/or cellular junctions, and imaged by deconvolution microscopy.
NA experiments. Samples were incubated with 500 l supplemented RPMI 1640 medium for an hour, prior to neuraminidase (NA) and virus addition, to allow for mucus production. After initial incubation, the medium was removed, and samples were treated with 1.2 U NA (Sigma-Aldrich) and 500 l PA-GFP virus and supplemented RPMI 1640 medium at 37°C for 4 h. After incubation, the samples were processed as previously described.
EDTA experiments. EDTA-treated ectocervical samples were incubated for 2 h with 10 mM EDTA (Sigma-Aldrich) and washed with phosphatebuffered saline (PBS) prior to inoculation with 500 l virus plus supplemented RPMI 1640 medium, 4 h of incubation at 37°C, and processing.
Rhesus macaques. All adult female rhesus macaques (Macaca mulatta) were housed at the Tulane National Primate Research Center. All animal experiments were approved by Tulane Institutional Animal Care and Use Committee. Approximately 4 ml of high-titer PA-GFP-labeled HIV-1 was intravaginally applied to 3 anesthetized animals that were then returned to their cages for 4 to 12 h. One milliliter of fluorescently tagged bovine serum albumin (BSA) was concurrently applied with the viral inoculum in one animal. All macaques were subsequently euthanized, and HIV-1-exposed reproductive tracts were removed and processed for analysis. Multiple 1-cm 3 samples were harvested from the ectocervix, endocervix, and vagina, immediately snap-frozen in OCT, and stored at Ϫ80°C. To compare the human ex vivo and macaque in vivo transmission models, 4 nonchallenged macaques were euthanized, and reproductive tracts were removed for ex vivo studies. Explant samples were processed identically to human explant tissues.
Immunofluorescence. Frozen tissue sections (12 m) were fixed in 3.7% formaldehyde in PIPES [piperazine-N,N=-bis(2-ethanesulfonic acid)] buffer for 5 to 10 min followed by washing in cold PBS. Samples were blocked with normal donkey serum for 10 min and washed again. For identification of simple columnar epithelial structure, samples were stained with cytokeratin-7 (clone OV-TL; DakoCytomation) at room temperature (RT) for 1 h. For endocervical mucin identification, samples were incubated with Muc5ac (clone 45M1; Invitrogen) for 1 h, also at RT. Lastly, to identify target cells, tissue sections were stained with Langerin (clone DCG4; Beckman Coulter), CD4 (OKT4; Cell Marque), and CD68 for macrophages (clone EBM11; DakoCytomation) each for 1 h at RT. To highlight cellular glycoproteins in the stratified squamous epithelium, fluorescently tagged wheat germ agglutinin (WGA) (Invitrogen) was added at RT for 30 min. For identification of adherens junctions, frozen sections (12 m) were fixed at Ϫ20°C in a 1:1 methanol-acetone mixture for 5 to 10 min. An anti-HECD-1 protein antibody (A gift from Kathy Green at Northwestern University) was applied for 1 h at RT prior to washing and addition of a secondary antibody. Secondary antibodies (Jackson ImmunoResearch) used were labeled with rhodamine RedX or Cy5. Finally, Hoechst DAPI (4=,6-diamidino-2-phenylindole) (Invitrogen) was applied for 10 min to stain nuclei before a final wash with PBS. Mounting medium (DakoCytomation) and coverslips were applied to sections, sealed with clear nail polish, and stored at 4°C until imaged.
Imaging. Images were obtained by deconvolution microscopy on a DeltaVision RT system collected on a digital camera (CoolSNAP HQ; Photometrics) using a 20ϫ, 40ϫ, or 100ϫ oil objective. For virus penetration analyses, z-scan stacks were collected over 15 m for each image field at 100ϫ, and image analysis was performed with the softWoRx software (Applied Precision). To determine the extent of viral penetration, the distance from the epithelial surface to each virion was measured using the measuring capabilities of softWoRx software. Penetrators were defined as virions entering more than 1 m into the epithelium. For each sample, approximately 20 z-scan stack images were randomly obtained to allow the interaction of virus with genital mucosa to be compared across a large surface area. The regions imaged were 60 m wide and 12 m thick. Additionally, interstitial movement was determined through colocalization with WGA. Any particles located within the luminal cavity, floating tissue debris, or endocervical mucus were included in the analysis but were not counted as penetrating virions. For target cell studies, 40ϫ panel images were acquired to include the epithelium and the underlying connective tissue in ex vivo human samples. softWoRx analysis software was used to measure the shortest distance from intraepithelial target cells to the surface of tissue epithelium.
Statistical analysis. The data were collected in two ways: (i) the unit of measure is per image (z-scan) collecting the count of visible virions and number of penetrating virions or (ii) the unit of measure is for each virion in an image (z-scan) collecting the depth for each penetrating virion. There were two approaches to analyzing these data sets. In the first approach, there were three main outcomes summarized per sample: the average number of virions (average virions), the average number of penetrating virions (average penetration), and the maximum penetration depth of all of the images (max.-max.-depth). All three outcomes were modeled using linear mixed models (41) . Model building included all interaction terms, and the model was reduced by removal of nonsignificant terms. This was performed on four data sets: set 1, referenced as virus penetration into human cervical explants (n ϭ 35), including the covariates tissue type, virus tropism, and p24 concentration; set 2, additional human ex vivo endocervical data (n ϭ 6), including the covariate NA treatment; set 3, macaque in vivo BSA (n ϭ 1 macaque, 157 images), including the covariate of BSA penetration; and set 4, macaque ex vivo (n ϭ 4), with the covariate tissue type.
In the second approach, the data were not summarized per sample. The three models were a negative binomial generalized estimating equation (GEE) modeling the count of virions present on the tissue (all observations per image), a binomial GEE with logit link modeling the proportion of virions that penetrate the tissue (observations with at least 1 virion present per image), and a gamma GEE modeling the depth of penetration per virion. This approach was applied to two data sets: set 1, human ex vivo data examining the covariate EDTA treatment (n ϭ 3; 60 images); and set 2, macaque in vivo data (n ϭ 2; 1,194 images) examining the covariate tissue type. All limits of statistical significance were set at P Ͻ 0.05, and analyses were performed using SAS 9.3.
RESULTS

PA-GFP HIV-1.
To better characterize events involved in early HIV-1 transmission, we applied GFP-Vpr-labeled virus to human FRT explants (18) . In initial experiments, control experiments revealed a background of small green puncta indistinguishable from viral particles. To overcome this autofluorescence, we developed PA-GFP-labeled HIV-1 to visualize verifiable viral particles in the female genital epithelia (16) . PA-GFP allows for subtraction of preactivated fluorescence in tissue, making it possible to distinguish postactivation virus-specific fluorescence. PA-GFP-labeled viral particles appeared as unique signals only observed on post-activation images. Importantly, a key advantage of this photoactivatable system is the removal of any possible subjectivity, as data acquisition was inherently blinded while avoiding the detection of false positives. Thus, with this system, we could reliably detect individual virions despite tissue autofluorescence.
During photoactivation, tissue undergoes excitation, with the captured fluorescent image defining the autofluorescent background. Following photoactivation with 400-to 430-nm light, an additional image is captured revealing the location of any PA-GFP-labeled virions when pre-and postphotoactivation scans are overlaid. Photoactivated virus is identified as new green punctate signals not related to autofluorescence (see Fig. S1A in the supplemental material). Postphotoactivation, PA-GFP signal is increased ϳ5-to 10-fold above background levels, as illustrated with fluorescent deconvolution microscopy and softWoRx image analysis software (see Fig. S1B ). Capsid (p24) and matrix (p17) staining overlapping with PA-GFP HIV-1 confirmed the fluorescence observed was indeed from HIV-1 virions (see Fig. S1C and D). Photoactivatable signal was never present in negative-control samples, further illustrating specificity (data not shown).
PA-GFP HIV-1 in human cervical explants. To define the interactions of HIV-1 with FRT epithelia, we utilized a nonpolarized explant culture system in which ϳ0.5-cm 3 pieces of mucosal tissue were soaked in HIV-1-containing medium for 4 h. Explants were sectioned and examined for HIV-1 particles, as revealed by the photoactivation protocol described above. We compared the penetration levels of PA-GFP HIV-1 Ba-L , HIV-1 R73yu , HIV-1 HXB2/Bru3 , and HIV lacking envelope (HIV-1 ⌬Env ). Endocervical and ectocervical explants from 35 donors were collected, and random fields were examined for each donor sample. An example of the interaction of virus with the endocervical and ectocervical mucosal barriers is shown in Fig. 2A to C and D and E, respectively. These studies confirm HIV-1 can penetrate the columnar and squamous epithelial barriers of the FRT.
Analysis of 1,457 z-stack images from endocervical explants revealed 14,586 PA-GFP virions associated with the columnar epithelium. Of these, 11.8% (n ϭ 1,724) were found to penetrate the epithelium more than 1 m. Viral particles were often found within cells, consistent with previous reports of HIV-1 entering columnar epithelial cells through endocytosis (19) . The nearest distance to the lumen was determined, and the average depth of penetration was 8.54 Ϯ 0.20 m (Table 1) . Importantly, substantial heterogeneity was identified within and between individual donor explant samples, as it was common to identify impenetrable areas in the mucosal epithelia, while other areas demonstrated frequent viral penetration (Fig. 2H) . Also, deeply penetrating viral particles (Ͼ20 m) were visualized in endocervical explants from most donors. Overall, we observed HIV-1 penetrating to depths of 50 m, indicating the virus can breach the 10-to 20-m-thick layer of columnar epithelial cells to access underlying target cells. However, penetration of virions was relatively infrequent with only 1.18 penetrating virions per scan (p/z), as most scans revealed no virus penetration. Virions that failed to penetrate were either bound to the endocervical surface or within the mucus coating, demonstrating that the endocervical barrier remained intact.
Likewise, in matched ectocervical explants treated concurrently with endocervical tissue, we readily detected virus entering the intact squamous epithelia (Fig. 2D to F) . We identified 10,954 virions from 1,512 scans as associating with and/or penetrating the female squamous genital epithelia. The majority of virions (n ϭ 9,124) were observed bound to the epithelial surface or within superficial sloughing layers of the stratum corneum. Regardless, a slightly higher percentage of 16.71% (n ϭ 1,830) penetrated the squamous epithelium compared to the 11.8% of virions penetrating the columnar epithelia, with an average depth of 6.98 Ϯ 0.19 m. Again, PA-GFP HIV-1 penetrated to depths of up to 50 m, which was the physical limit of our fields of microscopic imaging. As seen in the endocervical explants, there was a large amount of heterogeneity both within and between individual donor explant samples, and deeply penetrating particles were detected in tissue from multiple donors (Fig. 2I) . Notably, the frequency of penetrating virions (1.21 p/z) was essentially the same as in endocervical explants (1.18 p/z) ( Table 1 ). Over 90% of penetrative virions appeared to enter the squamous epithelial tissue in an interstitial manner, as revealed by the association of viral particles with staining for epithelial cell surface glycoproteins (see Fig.  S2A in the supplemental material). These data contrasted with the intracellular localization of virions in the columnar epithelium of endocervical explants. However, similar to endocervical samples, most ectocervical z-scan samples exhibited robust barrier function, as no virus was observed to enter the squamous epithelium in the majority of examined regions.
To determine if HIV-1 penetration into mucosal barriers was influenced by viral tropism of the envelope proteins, we compared the abilities of different HIV-1 isolates to enter tissue explants. Previous studies showed that CCR5 (R5)-tropic HIV-1 strains are the sexually transmitted form of HIV-1; therefore, an additional R5-tropic strain, HIV-1 R73yu , was compared to CXCR4 (X4)-tropic HIV-1 HXB2/Bru3 and to particles lacking envelope (HIV-1 ⌬Env) in multiple tissue donor explants (see Fig. S2B in the supplemental material) (20, 21) . Overall, this analysis revealed no significant differences between viruses with different tropisms and particles lacking envelope in the ability to penetrate the mucosal barriers of human cervical explants.
To further compare interactions of HIV-1 with endocervical and ectocervical barriers, we plotted the number of penetrating viral particles against depth of penetration (Fig. 2G ). This showed that the means of entry of HIV-1 into distinct columnar and squamous epithelia were very similar after 4 h of HIV-1 exposure. HIV-1 entered both tissues in a gradient-like manner, with most virions located adjacent to the lumen. Furthermore, virion penetration was mostly superficial, with 74% of penetrators located in the superficial 10 m of tissue, and only a few were able to penetrate deeper into mucosal barriers. These data indicate that multiple areas of the FRT may be sites of cell-free viral transmission, with a few virions potentially encountering target cells (see Fig. S3 in the supplemental material).
Explants were exposed to viral preparations of different concentrations to determine the correlation between virus concentration and HIV-1 penetration. It was noted that viral p24 capsid concentration positively correlated with the number of HIV-1 particles penetrating explant tissue (P ϭ 0.003). Overall, there was a significant relationship between p24 concentration and depth of penetration, independent of virus tropism and tissue type (P ϭ 0.008); an increase in concentration resulted in an increase of penetration depth (a 0.15-m increase in penetration for every 100 ng/ml of p24 concentration). These results illustrate that the amount of penetrating virus and depth of penetration into mucosal barriers are concentration dependent.
It has been suggested that the columnar epithelium of the en-docervix represents a point of vulnerability to HIV-1 (2). It was thus anticipated that HIV-1 would more readily penetrate endocervical explants, as the epithelium is thinner and able to mediate active processes, such as endocytosis and transcytosis. In contrast, our studies revealed that both barriers had similar barrier efficiencies. We also observed in the cervical canal a layer of mucus coating the columnar epithelium, which is believed to provide a protective barrier against invading pathogens (22, 23) . Thus, we hypothesized cervical mucus might play a role in barrier function. Supporting this hypothesis, we consistently observed PA-GFP HIV-1 virions within the mucus barrier of explants ( Fig. 3A and  B) . Additionally, although a greater number of tissue-associated virions were noted in endocervical samples, ectocervical samples had a higher percentage of penetrating virions (11.82% and 16.71%, respectively), suggesting the possible presence of extra barriers to HIV-1 at the columnar surface. To analyze virus penetration without mucus hindrance, we added neuraminidase (NA) to donor-matched endocervical explants during virus inoculation. NA enzymes (sialidases) are glycoside hydrolase enzymes that remove sialic acid from mucins and disrupt the gel-forming interactions in mucus. Using NA, we decreased the amount of mucus within the lumen of endocervical samples ( Fig. 3C and D) . In NA-treated samples, there was a 2.5-fold increase in the number of HIV-1 Ba-L and HIV-1 ⌬Env virions that penetrated tissue. Likewise, there was a 2-fold increase in the number of penetrating virions in HIV-1 HXB2/Bru3 -inoculated samples treated with NA (Table 1) . Collectively, when total samples treated with NA were compared with untreated samples, NA treatment was a significant predictor of mean tissue-associated virions (P ϭ 0.024) and mean penetrating virions (P ϭ 0.018) (Fig. 3E and F) . These data are consistent with a protective role of cervical mucus in the upper FRT.
To determine whether penetrating virions could reach viral target cells, we examined HIV-1 target cell distribution of the ectocervical epithelium, focusing on LCs, macrophages, and CD4 ϩ T cells (see Fig. S3 in the supplemental material). When resident target cell depths were compared to viral penetration depths, LC populations were consistently found at the same depth from the lumen as penetrating virions. Furthermore, small numbers of macrophages were identified at depths that coincided with viral penetration. In contrast, CD4 ϩ T cells were typically observed deeper in the tissue, within the lamina propria, although they could also be rarely observed within the epithelium. These results illustrate that penetrating virus may have opportunity to encounter suprabasal target cells, despite the physical barrier provided by multiple layers of overlying cells.
In vivo macaque experimentation: 4-h inoculation. To ensure that viral penetration was not a product of explant tissue degradation (autolysis) during experimentation, in vivo studies using the rhesus macaque vaginal transmission model were performed. In these studies, each macaque FRT was intravaginally inoculated with PA-GFP HIV-1. Macaques were euthanized 4 h postinoculation, and tissue samples were divided into endocervix, ectocervix, and vagina and analyzed for virus. Similar to explant studies, the rhesus ectocervix and vagina contained many virions with similar gradient type penetration. Collectively, in the ectocervix of 2 macaques, 307 virions from 217 scans were detected. Among ectocervix-associated virions, 42.67% (n ϭ 131) penetrated the squamous epithelia to an average depth of 7.05 Ϯ 0.51 m. Likewise, 778 scans of vaginal epithelium revealed 1,003 tissue-associated virions, of which 25.32% (n ϭ 254) were penetrators ( Table 2 ). As observed in the explant studies, the majority of HIV-1 in the squamous epithelium was associated with cell surface staining; indicating virus was located interstitially ( Fig. 4A to C; see Fig. S2C in the supplemental material). This result reveals for the first time that HIV-1 can penetrate the squamous epithelium of the FRT of a living nonhuman primate. These data also validate the results obtained using the explant system, as virus penetration is not the result of tissue degradation.
In contrast, virions were rarely associated within the endocervical samples. A total of 200 scans were acquired from 2 animals, and only 3 virions were found associated with these tissues after in vivo exposure. Only a single virion was found to penetrate the columnar epithelium (Table 2) (Fig. 4D) . This was in distinct contrast to the general congruency of the ectocervix and endocervix virus association and penetration in human explants. Thus, in our in vivo model, the level of virus penetrating the endocervix was significantly reduced relative to that in the macaque squamous tissue of the ectocervix and vagina (P Ͻ 0.001) (Fig. 4D) . These results hint toward a substantial role for anatomical structure and mucus protection of the endocervix in situ.
We also analyzed the number and localization of PA-GFP HIV-1 virions 12 h postinoculation; however, only a small number of virions were detected. This suggests that mechanisms within a living FRT can eliminate virus ( Fig. 4E and Table 2 ). Importantly, virus was still found within the columnar epithelium of the endocervix and squamous epithelium of the ectocervix and vagina 12 h after inoculation. These data indicate that potentially infectious virions may still illicit infection for extended periods after initial exposure-a factor that should be taken into account during development of preventative strategies.
Ex vivo macaque studies. The results obtained for HIV-1 penetration of mucosal tissue revealed differences in the ability of virions to enter the endocervix after exposure in an intact FRT, especially compared to explants. A major difference between ex vivo and in vivo systems is the influence of anatomical structure. Although the endocervical epithelium of explants is directly exposed to virus, the columnar epithelium of a living animal is contained within a tubular structure filled with mucus. Alternatively, the mucosal barrier of the columnar epithelium in the macaque may simply be more robust than the human tissue.
To further explore differences in virus penetration between human explants and in vivo macaque studies, ex vivo rhesus macaque experiments were performed. Explants were cultured identically to human tissues and treated with PA-GFP HIV-1 for 4 h in vitro prior to processing. As seen in the living macaque, the ectocervix and vagina contained many virions, with the majority entering interstitially, mimicking both the human ex vivo and macaque in vivo models (Fig. 4F) . In the macaque explant ectocervix, 736 virions from 284 scans were found to interact with the female genital epithelia. Of virions associated with the ectocervix, 37.32% (n ϭ 106) were found to penetrate with an average depth of 7.29 m. Again, penetrating virions were rare, with only 0.370 p/z. Likewise, 1,838 scans of the ex vivo vaginal epithelium resulted in 496 associated virions, of which 16.12% (n ϭ 80) were penetrators. Penetration was detected at 0.430 p/z ( Table 2) . Although very few virions were found to associate with (0.05%) or penetrate (0.03%) the columnar epithelium of macaques in vivo, macaque explant studies displayed virion quantities similar to those in the ex vivo human analysis. For example, in the ex vivo macaque endocervix, 170 virions from 278 scans were identified as being associated with the columnar barrier ( Table 2) . Of these, 25.29% (n ϭ 43) penetrated the columnar epithelium. Thus, explants may bypass the anatomical consequences of the intact, mucus-filled endocervix. These data, combined with results obtained from NA-treated human explants, further support the possibility that mucus in the cervical os may offer a natural protective barrier against HIV-1 penetration in vivo.
BSA-cell junction analysis. To further explore squamous barrier function, we exposed human ectocervical explants to fluorescent bovine serum albumin (BSA) as a fluid-phase marker, which is small enough in size (ϳ66 kDa) to enter water-permeable spaces. These studies revealed BSA penetrated the superficial layers of the squamous epithelium (Fig. 5A) . We also stained for HECD-1, a protein present in AJs, to examine tissue structure and integrity. We observed a reciprocal relationship between penetration of the fluid-phase marker and cellular junctions, as BSA entered up to but not beyond the boundary defined by presence of AJs. Similar exposure of the macaque FRT revealed a heterogeneous pattern of BSA penetration (Fig. 5B ) reminiscent of what was observed for virus penetration of the squamous epithelium. To explore the relationship between the penetration of solute and virus into mucosal barriers of the macaque FRT, we vaginally coinoculated with a mixture of PA-GFP HIV-1 and fluorescent BSA. We then specifically examined regions of vaginal tissue where BSA either penetrated more or less than 5 m into the squamous epithelium. This revealed 0.34 particle detected per scan in regions where BSA penetrated less than 5 m, while 3.5 virions were detected per scan in regions where the fluid-phase marker penetrated more than 5 m into the macaque vaginal epithelium. Thus, virus penetration was approximately 10-fold more common in areas where BSA penetrated to depths greater than 5 m (P Ͻ 0.001) (Fig. 5C and Table 3 ). These data indicate HIV-1 more readily penetrates areas where epithelial barriers may be compromised. Additionally, this suggests HIV-1 is able to enter mucosa in a similar manner to water, revealing diffusion through a porous medium (diffusive percolation) as the mechanism of virus penetration of tissue.
We next examined the distribution of intercellular junction barrier proteins that impeded fluorescent BSA ingress in human explants. Of these, TJs and AJs are known to prevent simple diffusion of particles between epithelial cells and may serve to hinder movement of virions into tissue (24, 25) . Previous studies illustrated robust cellular junction protein expression as decreased or absent in superficial layers of the squamous epithelium (26) . Furthermore, expression of these proteins overlapped within tissues. Qualitative analysis revealed these proteins were less prevalent in squamous epithelial areas associated with greater virus and fluidphase marker penetration (26) .
Quantification of relationships between virus penetration and cellular junctions was achieved by comparing virus penetration to depth of robust AJ protein expression (Fig. 5D) . These results showed virus penetration was only rarely observed beyond the boundary of AJs, with only 3 of 124 virions (97%) observed penetrating areas where cellular junctions were intact. Interestingly, all 3 virions penetrating into the region of AJs appeared to be cell associated, possibly carried there by a resident LC (data not shown). Additionally, to further corroborate cellular junction roles in prohibiting virus penetration, EDTA, a polyamino-carboxylic acid, was utilized to dissociate the robust barriers formed by AJs and TJs (27, 28) . EDTA treatment of explants resulted in a statistical increase in depth of HIV-1 Ba-L virus penetration (P ϭ 0.001) and a statistical increase in the number of penetrating virions (P Ͻ 0.001) (Fig. 5E and Table 3 ). These data support the hypothesis that initial virus penetration of epithelial squamous barriers occurs in a simple diffusion-based manner, not via HIV-1 envelope interaction with cellular receptors, until hindered by the presence of AJs and TJs. 
DISCUSSION
The simple columnar epithelium of the endocervix and the transformation zone have been proposed as the favored sites for HIV-1 transmission in women, largely due to the single layer of cells protecting underlying target cells and close proximity of target cells. Conversely, a healthy, intact squamous epithelium was assumed to be an efficient barrier to viral entry, as it is comprised of multiple cellular layers (2). Our novel PA-GFP HIV-1 enabled observation of HIV-1 effectively penetrating intact squamous epithelium of the vagina and ectocervix ( Fig. 2A to C and G) . Importantly, this observation casts considerable doubt on the effectiveness of the intact squamous epithelium as a barrier to HIV-1. Our studies also confirm that HIV-1 can interact with and penetrate the columnar epithelium of the endocervix. However, comparative in vivo experiments using the rhesus macaque model indicate that mucus production and anatomical structure may impede the efficiency of viral interactions and penetration in this tissue. Overall, these data suggest the lower FRT is more susceptible to HIV-1 penetration than previously thought and could be an important factor in male-to-female transmission of HIV-1, particularly given the high surface area of the lower FRT.
In our analyses, we show that the majority of penetrating virions were located within 2 m of the lumen and rarely penetrated past 10 m (Fig. 2) . In human cervical explants, we also identified a high level of heterogeneity among individual samples ( Fig. 2H  and I ). This heterogeneity could be attributed to a number of genetic and biological factors, such as mucus production, as the endocervical epithelium is unique in containing subepithelial goblet cells responsible for producing copious amounts of mucus (29) . In support of this, when comparing ex vivo macaque studies to the living model, we noticed a reduced ability of virus to enter the endocervical lumen in the in vivo macaque system (Fig. 4A to D and F and Table 2 ). This is possibly due to the efferent flow of mucus through the cervical canal flushing virions from the lumen, or the hindrance of mucus to individual HIV-1 particles. Similarly, the possible protective effects of mucus were highlighted in experiments where NA was applied to human endocervical explants during virus inoculation. The results of NA-treated explants illustrate that when mucus is depleted, virions can more readily interact with and penetrate the columnar epithelium of the endocervix (Fig. 3 and Table 1) .
Although we clearly demonstrate that virus can interact with and penetrate the columnar epithelium of the upper FRT, we also propose a route for HIV-1 transmission in the lower FRT that was largely discounted previously. In our human explants, we found HIV-1 penetrates the squamous epithelia of the ectocervix. Again, the majority of virions were located within 2 m of the lumen and rarely penetrated past 10 m (Fig. 2D to G) . Furthermore, as observed in endocervical human explants, there was also a high level of heterogeneity found within and between individual squamous explants, suggesting local epithelial differences in squamous tissue may influence HIV-1 penetration of the mucosa (Fig. 2I) . Additionally, using the macaque model, we show the ability of HIV-1 to penetrate squamous epithelium under in vivo conditions, recapitulating virus penetration results obtained in human cervical explants (Fig. 4A to D) . This suggests the explant data are not a consequence of tissue degradation following surgical removal. However, in comparison to the human explants, fewer virions were identified in squamous epithelium of the living macaque (Table 2) . This is likely due to inoculum leakage from motile macaques and a larger specimen surface area than is present in explants. This is supported by results of macaque explants, which were very similar to human explants (Tables 1 and 2 ). However, although virus penetration was relatively infrequent within in vivo squamous epithelia, other research has shown only a single founder virus is required for host infection in 80% of heterosexual transmission cases (30) .
In addition to demonstrating that HIV-1 could penetrate the intact lower FRT, we identified the mechanism in which virions penetrate squamous epithelium. The majority of infiltrating virions (90%) breached the epithelial defenses through simple diffusive percolation into tissues through interstitial spaces (see Fig.  S2A in the supplemental material). We also show that R5, X4, and ⌬-envelope viruses can breach squamous barriers with similar efficacy (see Fig. S2B ). Additionally, we confirmed HIV-1 was able to infiltrate the interstitial spaces of squamous epithelium in vivo (67%) (see Fig. S2C ). Furthermore, penetrating HIV-1 primarily colocalized within areas of epithelium costained with the diffusion marker BSA (Fig. 5A to C and Table 3 ). BSA only infiltrated where cellular junctions were compromised or absent, which is specific visualization of FRT that had compromised barrier function. Cellular junction proteins also limited virus penetration, as only cellassociated virions were found to penetrate areas with intact cellular junctions (Fig. 5D) (data not shown) . Furthermore, when EDTA was added to cervical samples to disrupt cellular junctions, a greater amount of virus was observed to penetrate samples, and to greater depths, than in nontreated explants, thereby increasing the potential of viral infection of suprabasal target cells, such as LC dendrites, mac- Table 3 ; see Fig. S3 in the supplemental material). This supports the hypothesis of a largely diffusion-based model of viral access into the superficial squamous epithelia, up to depths where cellular junctions are robust.
By comparing numbers of penetrating virions in each human explant donor sample to the respective inoculum titers, we also demonstrated that penetration is dependent on viral concentration. Our data suggest a linear correlation between viral concentration load and ability of HIV-1 to penetrate cervical epithelial barriers, with a 0.15-m increase in penetration for every 100 ng/ml of p24, a finding that correlates well with both our proposed diffusive percolation model, and also with epidemiological studies of transmission efficacy (30) . Incidentally, at later time points in the macaque model, virions were observed at the luminal surface and were penetrating both vaginal and endocervical tissues, although there were fewer of them ( Fig.  4E and Table 2 ). These data suggest potentially infectious virus is able to persist in the squamous and columnar epithelium of the FRT well after initial exposure, although they also reveal potential in vivo clearing mechanisms.
In summary, we propose the following model of HIV-1 interaction with the FRT (Fig. 6 ). In the majority of exposures, only a minority of infectious virions can penetrate intact FRT and even more rarely to areas where potential target cells reside (Fig. 6A) . The healthy stratified squamous epithelium largely acts as a robust barrier to pathogen ingress, but it is not impenetrable. Furthermore, in areas where epithelium integrity is compromised and cellular junctions are either absent or degraded, virions can readily interact with or penetrate the barrier provided by vaginal and ectocervical epithelia. In these instances, virions are more likely to encounter resident intraepithelial LCs and other viral target cells. Whether resident LCs protect against HIV-1 infection or aid viral transmission remains debated (13, (31) (32) (33) . Moreover, how inflammatory genital conditions enhance HIV-1 transmission is poorly understood. Inflammation is known to increase the density of activated T cells, bringing them in closer proximity to infectious viruses in the lumen (Fig. 6B) (11, 34) . This recruitment of target cells, coupled with upregulation of proinflammatory (interleukin-1␤ [IL-1␤], IL-6, and tumor necrosis factor alpha [TNF-␣]) and immunoregulatory (IL-10 and IL-12) cytokines, could provide an explanation for enhanced HIV-1 transmission efficacy during coinfections with inflammatory sexually transmitted infections (STIs) (22) .
Through the extrapolation of our data, we can model male-tofemale sexual transmission in the lower FRT and estimate the number of HIV-1 penetrating virions per coital act (Fig. 7) . Spe- virions/cm 2 . Furthermore, since penetration depends on viral concentration, we assume a linear relationship between the number of penetrators and virus concentration. Therefore, at 500 ng/ml p24, the concentration of virus (C v exp ) is 3.95 ϫ 10 9 virions/ml. However, these data are denotative of experimental high viral titers and not reflective of natural infection. Clinically, an acutely infected male is reported to have maximum input virus concentration (C v in vivo ) of 4.0 ϫ 10 6 virions/ml; that for chronic infection is reported to be 5.0 ϫ 10 3 virions/ml (35, 36) . Therefore, in the squamous epithelium, we used approximately 10 3 ϫ and 10 6 ϫ higher concentrations of virus than occur in acute and chronic male-to-female transmission. To adjust, we scaled the penetrator surface density value to the ratio of in vivo and experimental viral concentrations, and vaginal surface area (A vag ; 87.5 cm 2 ), allowing us to estimate the total number of viral penetrators in vivo (N p in vivo ) under both acute and chronic transmission conditions: N p in vivo ϭ v ϫ (C v in vivo /C v exp ) ϫ A vag .
Thus, we find 1.49 ϫ 10 4 and 18 virions potentially penetrating the squamous epithelium per coital act at the highest detected acute and chronic levels of infection, respectively (37) .
In the endocervix, although the efficiencies of virus penetration in both epithelia were similar (Table 1) , the simple columnar epithelium has a smaller surface area resulting in fewer penetrating virions (Fig. 7) . Assuming a maximum endocervical area (A endo ) of 20.0 cm 2 , 3.40 ϫ 10 3 and 4 virions can be calculated for acute and chronic levels, respectively (38) . This is clearly an overestimate, as this model does not take into account the presence of cervical mucus that would likely alter virus entry characteristics. For instance, we failed to locate virions within the mucus-filled crypts of the cervical canal. Thus, anatomy clearly plays a role here. We also located few virions in the endocervix of our in vivo studies. The cervical tube full of mucus migrating outwards over time makes for a formidable barrier for the virus. Furthermore, mucus contains antiviral proteins that may play an inhibitory role in HIV-1 transmission, as endocervical tissue can produce peptide defensins and secretory leukocyte protease inhibitors that inhibit HIV-1 infection (39) . Overall, these inefficient interactions of virus to overcome both intact mucosal barriers are in agreement with known characteristics of transmission: the ability of a small number of virions to initiate transmission is consistent with low per coital transmission rates, especially under conditions of chronic infection in discordant, heterosexual couples (30, 40) .
In conclusion, we propose a route for HIV-1 transmission in the lower FRT that was largely discounted previously. Our BSA and EDTA experiments with squamous epithelium reveal virus penetration depths are directly proportional to epithelial permeability, especially in areas where cell junctions are absent. We also demonstrate virus penetration is linear over a wide range of concentrations. These findings suggest a simple diffusion mechanism for the initial events of HIV-1 entry into the epithelium of the lower FRT and clearly point to the squamous mucosa as another potential site for HIV-1 transmission and infection. Furthermore, our results also provide a biological description of the functional virus dose of HIV-1 during transmission. These studies should positively impact the development of novel HIV-1 preventative technologies.
